NASDAQ: ALVRAllovir Inc Stock Ownership - Who owns Allovir?
Insider buying vs selling
Have Allovir Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Edward Miller | General Counsel | 2025-01-10 | 409 | $0.44 | $179.96Sell |
| Vikas Sinha | Officer Title President Chief Financial Officer and Chief Executive Officer | 2025-01-10 | 979 | $0.44 | $430.76Sell |
| Brett R. Hagen | Chief Accounting Officer | 2025-01-10 | 332 | $0.44 | $146.08Sell |
| Vikas Sinha | Officer Title President and Chief Financial Officer | 2024-11-19 | 3,186 | $0.55 | $1.75kSell |
| Diana Brainard | Chief Executive Officer | 2024-11-19 | 8,706 | $0.55 | $4.77kSell |
| Brett R. Hagen | Chief Accounting Officer | 2024-11-19 | 554 | $0.55 | $303.59Sell |
| Edward Miller | General Counsel | 2024-11-19 | 432 | $0.55 | $236.74Sell |
| Brett R. Hagen | Chief Accounting Officer | 2024-11-05 | 1,655 | $0.87 | $1.43kSell |
| Edward Miller | General Counsel | 2024-11-05 | 2,272 | $0.87 | $1.97kSell |
| Vikas Sinha | Officer Title President and Chief Financial Officer | 2024-11-05 | 5,136 | $0.87 | $4.44kSell |
ALVR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ALVR insiders and whales buy or sell their stock.
ALVR Shareholders
What type of owners hold Allovir Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Morana Jovanembiricos | 1,582.67% | 79,502,507 | $810.13M | Insider |
| David Hallal | 1,387.56% | 69,701,844 | $710.26M | Insider |
| Vikas Sinha | 953.76% | 47,910,417 | $488.21M | Insider |
| Ansbert Gadicke | 599.72% | 30,125,933 | $306.98M | Insider |
| Elevatebio LLC | 331.95% | 16,674,766 | $169.92M | Insider |
| Gilead Sciences Inc | 331.16% | 16,635,286 | $169.51M | Insider |
| Ecor1 Capital LLC | 224.84% | 11,294,585 | $115.09M | Institution |
| Octagon Capital Advisors LP | 223.00% | 11,202,000 | $114.15M | Institution |
| F2 Mg Ltd | 195.65% | 9,828,091 | $100.15M | Insider |
| John Robert Wilson | 173.75% | 8,727,908 | $88.94M | Insider |
ALVR vs Biotech Stocks
Allovir Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.